CapyFin

Loading...

CapyFin Real-time Earnings Reports.

Products

Earnings

Get in Touch

Contact Us
X (Twitter)
LinkedIn

Resources

Privacy Policy
Terms of Service
Sign Up
Sign In

© 2025 CapyFin. All rights reserved.

Disclaimer: This platform provides information and recommendations for educational purposes only and is not a substitute for professional financial advice. Our content covers a range of investment classes, including stocks and cryptocurrencies, and we do not guarantee the completeness, accuracy, reliability, or suitability of this information, which may include data from third-party services and content generated by artificial intelligence (AI). Investing in stocks, cryptocurrencies, and other financial instruments involves risks, including the potential loss of principal. Users should independently verify all information and seek advice from qualified professionals tailored to their individual financial situations and investment objectives. Our content and services are provided "as is" without any warranties, express or implied. We are not liable for any losses or damages arising from the use of our services. This disclaimer is subject to change; users are advised to review it periodically. Usage of our services constitutes acceptance of these terms.

🇺🇸 NASDAQ:ACTG

Overview Earnings Dividends

May 17, 2021

•

Mar 31, 2021

Acacia Q1 2021 Earnings Report

Acacia Research reported financial results for the first quarter of 2021.

Key Takeaways

Acacia Research reported its Q1 2021 financial results, with a focus on evaluating new strategic opportunities and ongoing IP investments. The company led the reconstitution of the Board of Directors of Arix Bioscience plc, where Acacia is a significant shareholder.

Ongoing evaluation of new strategic opportunities in collaboration with Starboard Value LP.

Focus on acquiring operating companies in mature technology, healthcare, industrial, and financial services segments.

IP investments have resulted in a balanced portfolio.

Led the reconstitution of the Board of Directors of Arix Bioscience plc.

Total Revenue

$5.8M

Previous year: $3.82M

+52.1%

EPS

-$2.81

Previous year: -$0.24

+1070.8%

Book Value Per Share

$2.64

Gross Profit

$490K

Previous year: $1.31M

-62.6%

Cash and Equivalents

$157M

Previous year: $58.7M

+168.2%

Free Cash Flow

-$6.15M

Previous year: -$2.37M

+159.2%

Total Assets

$231M

Previous year: $214M

+8.0%

Acacia

Acacia

Forward Guidance

Acacia Research focuses on acquiring operating companies in the mature technology, healthcare, industrial and certain financial services segments.

Company Overview

Full financial data and analysis